Sharon Bio-Medicine Ltd

Key Stats

₹3.1
Day's Price Range
₹3.3
₹0
52-Week Price Range
₹3.3

Company Financials

  • Quarterly
  • Annual
Value in ₹ crore

Peer Comparsion

PE
Rank 286
-0.12
EPS
Rank 292
₹-26.78
BVPS
Rank 301
₹-16.41
Dividend Yield
Rank 176
ROE
Rank 445
Price To Book Ratio
Rank 248
-0.2
Debt To Asset
Rank 11
1.25

Company Information

Incorporated in 1989Sharon BioMedicine Ltd is engaged in the pharmaceuticals/chemicals segment.The company had developed a number of products in active pharmaceutical ingredient API intermediates and formulations. During the fiscal year ended June 30 2010 it had set up an active pharmaceutical ingredients plant in Taloja near Navi Mumbai.The company had installed capacity of 150000 liters of reactors capacity of API and intermediates and 2.5 billion tablets per shift per annum and one billion capsules per shift per annum. Its products include Trimetazidine Di Hydrochloride Ketoconzole Pentaprazole Amlodipine Besylate Atomoxetine Hcl Carisoprodl Closantel Base Glimepiride Ketoconazole Nifedipibe Racecadotril Toldimfos Telmisartan Tamsulosin Itraconazole Mesalazine Lansoprazole and Doxorubicin Inj.In January 2010the Company started its toxicology laboratory and research and development unit at Taloja Navi Mumbai.
OrganisationSharon Bio-Medicine Ltd
HeadquartersRaigad
IndustryPharmaceuticals